Friday Pop Quiz 12/6/2024
Which of the following is the most appropriate initial treatment for the condition pictured?
A. Prednisone
B. Mycophenolate mofetil
C. Infliximab
D. Cyclosporine
E. Doxycycline
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
Adam Smith’s famous book, The Wealth of Nations, published in Great Britain …
Which of the following is the most appropriate initial treatment for the condition pictured?
A. Prednisone
B. Mycophenolate mofetil
C. Infliximab
D. Cyclosporine
E. Doxycycline
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
Adam Smith’s famous book, The Wealth of Nations, published in Great Britain … 
Patients with the above condition should be evaluated for what immunodeficiency?
A. C5-9
B. IgM
C. C3
D. B2-integrin
E. Immunoglobulin
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
A 28-year-old female patient presents with the recent onset of lesions on her right forearm, as shown. She notes that her mother has a history of similar lesions and has a history of pernicious anemia. On examination, she has no lesions elsewhere on her body. Which of the following patient factors is most associated with disease progression in the patient’s condition?
A. Age
B. Family … 
Biopsy of this lesion reveals massive papillary dermal edema, a diffuse neutrophilic infiltrate, and a lack of vasculitis. Stains for infectious organisms are negative. What is the first line treatment?
A. Dapsone
B. Colchicine
C. Thalidomide
D. Potassium iodide
E. Prednisone
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partn … 
The patient developed this cutaneous adverse event 2 weeks after starting a clinical trial medication. What is the mechanism of action of the culprit medication?
A. Epidermal growth factor receptor (EGFR) inhibitor
B. Tumor necrosis factor (TNF)-alpha inhibitor
C. Smoothened inhibitor
D. BRAF inhibitor
E. Programmed cell death (PD)-1 inhibitor
To find out the correct answer and …